Demir, B. Et Al. 2022. SCLERODERMA CLINICAL TRIALS CONSORTIUM DAMAGE INDEX (SCTC-DI): ASSESSMENT OF PROGRESSION IN A SINGLE CENTER COHORT. 7th Systemic Sclerosis World Congress , 1.

Demir, B., Yalçınkaya, Y., Can, M. G., Aliyeva, N., Amikishiyev, S., Gül, A., ... Artım Esen, B.(2022). SCLERODERMA CLINICAL TRIALS CONSORTIUM DAMAGE INDEX (SCTC-DI): ASSESSMENT OF PROGRESSION IN A SINGLE CENTER COHORT . 7th Systemic Sclerosis World Congress (pp.1).

Demir, Büşra Et Al. "SCLERODERMA CLINICAL TRIALS CONSORTIUM DAMAGE INDEX (SCTC-DI): ASSESSMENT OF PROGRESSION IN A SINGLE CENTER COHORT," 7th Systemic Sclerosis World Congress, 2022

Demir, Büşra Et Al. "SCLERODERMA CLINICAL TRIALS CONSORTIUM DAMAGE INDEX (SCTC-DI): ASSESSMENT OF PROGRESSION IN A SINGLE CENTER COHORT." 7th Systemic Sclerosis World Congress , pp.1, 2022

Demir, B. Et Al. (2022) . "SCLERODERMA CLINICAL TRIALS CONSORTIUM DAMAGE INDEX (SCTC-DI): ASSESSMENT OF PROGRESSION IN A SINGLE CENTER COHORT." 7th Systemic Sclerosis World Congress , p.1.

@conferencepaper{conferencepaper, author={Büşra DEMİR Et Al. }, title={SCLERODERMA CLINICAL TRIALS CONSORTIUM DAMAGE INDEX (SCTC-DI): ASSESSMENT OF PROGRESSION IN A SINGLE CENTER COHORT}, congress name={7th Systemic Sclerosis World Congress}, city={}, country={}, year={2022}, pages={1} }